Report on Corporate Governance

Asia Vets Holdings Ltd. (the “Company”) was admitted to the Official List of the SGX-Catalist on 19 July 2010.

The board of directors of the Company (the “Board”) believes in having high standards of corporate governance and is committed to ensuring that effective self-regulatory corporate practices exist to protect the interests of shareholders of the Company (the “Shareholders”) and maximise long-term Shareholders’ values.

In accordance with Rule 710 of the Singapore Exchange Securities Trading Limited (“SGX-ST”) Listing Manual Section B: Rules of Catalist (the “Catalist Rules”), the following report describes the Company’s corporate governance practices for the financial year ended 31 December 2023 (“FY2023”) with specific reference to the Principles and Provisions set out in the Code of Corporate Governance 2018 (the “Code”), and the Practice Guidance dated 14 December 2023 (“Practice Guidance”).

The Board is pleased to report that, for FY2023, the Company has complied with the Principles of the Code, and the Provisions of the Code (except where otherwise explained). In areas where the Company’s practices vary from any Provisions of the Code, the Company has stated herein the Provision of the Code from which it has varied, and appropriate explanations are provided for the variation, and how the practices the Company had adopted are consistent with the intent of the relevant Principle of the Code. The Company will continue to assess its needs and implement appropriate practices accordingly.

Principle 1: The Board’s Conduct of Affairs

The Company is headed by an effective Board which is collectively responsible and works with Management for the long-term success of the Company.

Provision 1.1

Principal Duties of the Board

The Company is headed by an effective Board to lead and control the Company. The Board has the overall responsibility for corporate governance, strategic direction and investments of the Company. Each individual director of the Company (“Director”) is obliged to act in good faith and exercise independent judgment in the best interests of Shareholders at all times.

The Board’s principal functions include:

  • determining, reviewing and approving the strategic objectives and directions of the Company, annual budgets, major investments, divestments and funding proposals;

  • overseeing the business and affairs of the Company, establishing with the management of the Company (the “Management”) the strategies and financial objectives to be implemented by the Management, and monitoring the performance of the Management; 
  • establishing a framework of prudent and effective controls which enables risk to be assessed and managed, including safeguarding of Shareholders’ interests and the Company’s assets;

  • setting the Company’s values and standards (including ethical standards), and ensuring that obligations to Shareholders and other stakeholders are understood and met; 

  • reviewing Management performance, the Company’s financial performance, risk processes and systems, human resource requirements and corporate governance practices; 

  • considering sustainability issues, e.g. economic, social and governance factors, as part of its strategic formulating; and

  • identifying the key stakeholder groups and recognising that their perceptions affect the Company’s reputation. 

All Directors must objectively discharge their duties and responsibilities at all times as fiduciaries in the interests of the Company and hold Management accountable for performance.   

Code of Business Conduct and Ethics

The Company has established a Code of Business Conduct and Ethics that sets the principles of the code of business conduct and ethics which applies to all employees of the Group. Directors, key management personnel and employees of the Group are expected to observe and uphold the highest possible standards of ethical, moral and legal business conduct and to be in compliance with the law and regulations at all times and all places in the world.

Conflict of Interests

Each Director is required to promptly disclose any conflict or potential conflict of interest, whether direct or indirect, in relation to a transaction or proposed transaction with the Group as soon as is practicable after the relevant facts have come to his or her knowledge. On an annual basis, each Director is also required to submit details of his or her associates for the purpose of monitoring interested persons transactions. Where a Director has a conflict or potential conflict of interest in relation to any matter, he or she should immediately declare his or her interest when the conflict- related matter is discussed, unless the Board is of the opinion that his or her presence and participation is necessary to enhance the efficacy of such discussion. Nonetheless, he or she is to abstain from voting in relation to the conflict- related matters.

Provision 1.2

Appointment Letter

Newly appointed Directors will be provided a formal letter of appointment setting out among other matters, the roles, obligations, duties and responsibilities of the Director as a member of the Board.

Directors’ Orientation and Training

All newly appointed Directors will be given appropriate briefings by the Management on the business activities of the Company, its strategic directions and the Company’s corporate governance policies and practices. Directors will also be given the opportunity to visit the Group’s operational facilities and to meet with the Management to gain a better understanding of the Group’s business operations. The Company will also arrange for first-time Directors to attend the relevant training in relation to the roles and responsibilities of a director of a listed company as required under Rule 406(3)(a) of the Catalist Rules, as well as other courses relating to areas such as accounting, legal and industry specific knowledge as appropriate, organised by other training institutions. The training of Directors will be arranged and funded by the Company. No new Director was appointed to the Board in FY2023.

Existing Directors will be updated regularly on accounting and regulatory changes by the Company’s external auditors, continuing sponsor and company secretary, and are encouraged to attend workshops, seminars and training, to enhance their skills and knowledge, or on relevant new laws, regulations and changing commercial risks, and such training will be funded by the Company.

Seminars and Trainings attended by Directors in FY2023

The details of updates, seminars and training programmes attended by the Directors in FY2023 include, amongst others:

  • updates on developments in financial reporting and governance standards, as and when there are updates and where relevant, by the external auditors of the Company; and

  • updates on regulatory announcements, guidance and/or amendments to the Catalist Rules and the Code, as and when there are updates and where relevant, by the continuing sponsor and company secretary of the Company.

Provision 1.3

Matters Requiring the Board’s Approval

The Group has adopted internal guidelines governing matters that require the Board’s approval which has been clearly communicated to the Management.

The Board has identified, without limitation, the following matters that require its approval:

  • declaration of dividends and other returns to shareholders;

  • major corporate policies on key areas of operation;

  • major funding proposals or bank borrowings;

  • corporate or financial restructuring and share issuances;

  • mergers and acquisitions;

  • material acquisitions and disposals;

  • approval of transactions involving interested person transactions; and

  • appointments of new Directors.

Provision 1.4

Delegation by the Board

To assist the Board in the discharge of its functions, the Audit Committee, the Nominating Committee and the Remuneration Committee (collectively, “Board Committees”) have been constituted with written terms of reference which clearly sets out the authority and duties. These terms of reference are reviewed on a regular basis, along with the respective Board Committees’ structures and composition, to ensure their continued relevance, taking into consideration the changes in the governance and legal environment. Any change to the terms of reference for any Board Committee requires the specific written approval of the Board. Matters which are delegated to the Board Committees for more detailed appraisals are reported to and monitored by the Board.

Please refer to the various Principles in this Report on Corporate Governance for further information on the names of the members of the respective Board Committees, their terms of reference and the activities of the respective Board Committees.

Provision 1.5

Board and Board Committees Meetings and Attendance

The Board meets at least two (2) times a year, and whenever warranted by particular circumstances, as deemed appropriate by the Board members. Directors are free to discuss and voice their concerns on any matter raised at the Board meetings. Telephonic and video-conference meetings of the Board are allowed under the Company’s Constitution. All Directors are provided with the agenda and a set of the Board papers prior to the Board meeting. These are issued in advance to give the Directors sufficient time to better understand the matters to be discussed and to obtain further clarifications or explanations at the Board meeting where necessary. The Company and the Board acknowledge that an unimpeded flow of relevant information in a timely manner is crucial for the Board to be effective in discharging its duties and responsibilities.

The attendance of the Directors at meetings of the Board and Board Committees held in FY2023 is set out as follows:

Name of Directors

Board

Audit Committee

Nominating Committee

Remuneration Committee

No. of meetings held while being a member

No. of meetings attended

No. of meetings held while being a member

No. of meetings attended

No. of meetings held while being a member

No. of meetings attended

No. of meetings held while being a member

No. of meetings attended

Tan Tong Guan

2

2

2 *

  1 *

1 *

Tan Geok Moey

2

2

2

2

1

1

1

Kim Seah Teck Kim

2

2

2

2

1

1

1

1

Henry Tan Song Kok

2

2

2

2

1

1

1

1

 

* Attended by invitation.

 

Multiple Board Representations

All Directors are required to declare their board representations on an annual basis and as soon as practicable after the relevant facts have come to his or her knowledge. Where a Director has multiple board representations, and in considering the nomination of Directors for appointment, the Nominating Committee will evaluate whether or not the Director is able to and has been adequately carrying out his or her duties as a Director, as well as sufficient time and attention are given to the affairs of the Company, taking into consideration the Director’s number of listed company board representations and other principal commitments.

The Nominating Committee noted that some Directors have other principal commitments, while others have both multiple listed company board representations and other principal commitments. In particular, the Nominating Committee noted that Mr Henry Tan Song Kok holds a significant number of such listed company board representations and other principal commitments as well as Mr Kim Seah Teck Kim. Notwithstanding, the Nominating Committee noted the aforesaid Directors’ commitments and contributions to the Company, which are evident in their level of attendance and active participation at Board and Board Committee meetings. Based on the above, the Nominating Committee has reviewed and is of the opinion that all the Directors are able to and have adequately carried out their duties as Directors of the Company, as well as sufficient time and attention are given by the Directors to the affairs of the Company in FY2023. In view of the above, the Board, with the concurrence of the Nominating Committee, is of the view that there is no need to implement internal guidelines (such as implementing a limit on the maximum number of listed company board representations which any Director may hold) to address competing time commitments. The Board believes that each individual Director is best placed to determine and ensure that he/she is able to devote sufficient time and attention to discharge his/her duties and responsibilities as a Director, bearing in mind his/her other commitments. The Board and the Nominating Committee will review the requirement to determine the maximum number of listed company board representations as and when they deem fit.

Provision 1.6

Access to Information

The Board is provided with complete, accurate, and adequate information in a timely manner, prior to Board meetings and on an on-going basis, to enable it to fulfill its responsibilities. Such information includes background or explanatory information relating to matters to be brought before the Board, copies of disclosure documents, budgets and monthly internal financial statements. In respect of budgets, any material variance between the projections and actual results will be disclosed and explained. Such information is provided to the Directors to enable them to keep abreast of the Company’s operational and financial performance and position and to facilitate better-informed decision-making.

Provision 1.7

Access to Management and Company Secretary 

The Directors have separate and independent access to the Management and the company secretary at all times. The company secretary and/or his or her representatives attend all Board meetings to ensure that Board procedures are followed and that applicable rules and regulations, including the requirements of the Companies Act 1967 of Singapore and the Catalist Rules are complied with. In addition, the company secretary and/or his or her representatives assists the Chairman, and the Chairman of each Board Committee in the development of the agendas for the various Board and Board Committees meetings. Under the direction of the Chairman, the company secretary’s other responsibilities include ensuring good information flows within the Board and Board Committees and between the Management, the Non-Independent and Non-Executive Director and the Independent Directors, as well as facilitating orientation and assisting with professional development as required. The appointment and the removal of the company secretary is a decision of the Board as a whole.

Independent Professional Advice

Should the Directors, whether as a group or individually, need independent professional advice in furtherance of their duties and responsibilities, the Company will appoint such professional adviser to render the appropriate professional advice. The cost of such professional advice will be borne by the Company.

Principle 2: Board Composition and Guidance

The Board has an appropriate level of independence and diversity of thought and background in its composition to enable it to make decisions in the best interests of the Company.

Provision 2.1

Director’s Independence 

The criterion for independence is based on the definition set out in the Code and Practice Guidance, and taking into consideration whether the Director falls under any circumstances pursuant to Rule 406(3)(d) of the Catalist Rules. The Board considers an “independent” Director as one who has no relationship with the Company, its related corporations, its substantial Shareholders or its officers that could interfere, or be reasonably perceived to interfere, with the exercise of the Director’s independent business judgment with a view to the best interests of the Company.

The Nominating Committee, shall conduct an annual review to determine the independence of the Directors according to the Code and its Practice Guidance, as well as Rule 406(3)(d) of the Catalist Rules. Under Rule 406(3)(d) of the Catalist Rules, a director will not be independent under any of the following circumstances: (i) if he is employed by the company or any of its related corporations for the current or any of the past three financial years; or (ii) if he has an immediate family member who is employed or has been employed by the company or any of its
related corporations for the past three financial years, and whose remuneration is determined by the remuneration committee of the company; or (iii) if he has been a director of the company for an aggregate period of more than nine years (whether before or after listing), and such director may continue to be considered independent until the conclusion of the next annual general meeting of the company. In its review, the Nominating Committee shall consider all nature of relationships and circumstances that could influence the judgement and decisions of the Directors before tabling its finding and recommendations to the Board for approval.

The Independent Directors (namely Mr Kim Seah Teck Kim and Mr Henry Tan Song Kok) have confirmed that they or their immediate family members do not have any relationship with the Company or any of its related corporations, its substantial Shareholders or its officers that could interfere, or be reasonably perceived to interfere, with the exercise of the Directors’ independent business judgment with a view to the best interests of the Company, and do not fall under any of the circumstances pursuant to Rule 406(3)(d) of the Catalist Rules. The Independent Directors did not own shares of the Company and were not in any foreseeable situation that could compromise their independence of thought and decision. The Board, based on the review conducted by the Nominating Committee, has determined that the said Directors are independent. The Independent Directors, being the members of the Nominating Committee, have each abstained from making any recommendation and/or participating in any deliberation of the Nominating Committee in respect of the assessment of their own independence as a director.

None of the Independent Directors has served on the Board beyond nine (9) years from the date of his or her first appointment.

Provision 2.2

Proportion of Independent Directors

As of the date of this report, the Board comprises of two (2) Independent Directors (out of a four (4) member Board), which constituted half of the Board. Although the Chairman of the Board is not independent and the Independent Directors does not make up majority of the Board as recommended by Provision 2.2 of the Code, the Board and the Nominating Committee are of the view that the Company complies with Principle 2 of the Code taking into consideration the following: (i) half of the Board consists of Independent Directors and majority of each of the Board Committees are Independent Directors, (ii) the decision making process of the Board is based on collective decisions so that no individual or groups of individuals can dominate the decision making process, and (iii) the Board has a Lead Independent Director, who will provide leadership in situations where the Executive Chairman and Chief Executive Officer may be conflicted. Nevertheless, the Nominating Committee will continue to review and monitor the requirement for a majority of the Board to be Independent Directors, to be in line with the Provision 2.2 of the Code.

Provision 2.3

Proportion of Non-Executive Directors 

The Board comprises a majority of three (3) Directors (out of a four (4) member Board) who are Non-Executive Directors.

Provision 2.4

Board Composition and Size 

The Board currently comprises four (4) members, one (1) of whom is an Executive Director and three (3) of whom are Non-Executive Directors, of which two (2) are Independent Directors.

The Board members as of the date of this report are:

Tan Tong GuanExecutive Chairman and Chief Executive Officer 

Tan Geok MoeyNon-Independent and Non-Executive Director 

Henry Tan Song KokLead Independent Director

Kim Seah Teck KimIndependent Director

The Nominating Committee is responsible for examining the size and composition of the Board and Board Committees. Having considered the scope and nature of the Group’s businesses, the requirements of the business and the need to avoid undue disruptions from changes to the composition of the Board and Board Committees, the Board, in concurrence with the Nominating Committee, is of the view that the current size and composition of the Board and Board Committees, are appropriate to facilitate effective decision making, and provide sufficient diversity of expertise to lead and govern the Company effectively.

Board Diversity

The Company has a written board diversity policy which sets out the policy and framework for promoting diversity on the Board and believed that a diverse Board will enhance decision making of the Board by utilising the variety of skills, industry, and business experiences and competencies, gender, age, ethnicity and culture, geographical background and nationalities, tenure of services and other distinguishing qualities.

On annual basis, the Nominating Committee conducts its review of the composition of the Board, which comprises members of both genders and from different backgrounds whose core competencies, qualifications, skills and experiences, met with the requirements of the Group. The Nominating Committee will periodically review the competencies of the Directors to ensure effective governance of the Company and contribution to the Board. All Directors will submit to the Nominating Committee on an annual basis a completed Board and Board Committees
Evaluation Questionnaire (including composition of the Board and Board Committees). The Nominating Committee have reviewed the completed the Evaluation Questionnaire for FY2023, and is satisfied that the Board has the appropriate mix of expertise, knowledge, experiences, and skills in supporting the attainment of its strategic objectives and sustainable development.

The Board and the Board Committees currently comprise persons who as a group provide an appropriate balance and diversity of skills, experience and knowledge to the Company, as well as provide a diversity of gender with one (1) female Director who is a Non-Independent and Non-Executive Director (constitute 25% of the Board) in recognition of the importance and value of gender diversity. The Directors, as a group, provide core competencies such as accounting or finance, business or management experience, legal, industry knowledge, strategic planning
experience and customer-based experience or knowledge required for the Board and the Board Committees to be effective. The current composition of the Board is in line with the targets set in the Company’s board diversity policy. Nevertheless, the Company is constantly on the lookout for suitable candidates to join the Board as Independent Directors as part of its review process.

To address the dynamic business environment, the Nominating Committee will recommend the Board to consider the appointment of new Director(s) that has/have the required skillset, expertise, experience and knowledge as and when it deems necessary.

A brief profile of each Director is set out on pages 6 to 7 of the Annual Report. Information of the interests of the Directors who held office at the end of the financial year in shares, debentures and share options in the Company and its related corporations (other than the wholly-owned subsidiaries) are set out in the Directors’ Statement on page 79 of the Annual Report.

Provision 2.5

Meeting of Non-Executive Directors without Management

The Non-Independent and Non-Executive Director and the Independent Directors will assist to develop proposals on strategies and goals for the Company and regularly assess the performance of the Management in meeting the agreed goals and objectives, and monitor the reporting of performance. The Non-Independent and Non-Executive Director and the Independent Directors are encouraged to meet, without the presence of the Management, so as to facilitate a more effective check on the Management. They will meet on a need-basis without the presence of the Management to discuss on arising issues.

During FY2023, the Non-Independent and Non-Executive Director and the Independent Directors have met informally via physical/virtual meetings and communicated via emails without the presence of Management to discuss matters such as the Group’s financial performance, corporate governance initiatives, succession planning as well as leadership development and the remuneration of Directors and key management personnel.

Principle 3: Chairman and Chief Executive Officer

There is a clear division of responsibilities between the leadership of the Board and Management, and no one individual has unfettered powers of decision-making.

Provision 3.1

Separation of the Role of Chairman and Chief Executive Officer

The roles of the Executive Chairman and the Chief Executive Officer are currently held by Mr Tan Tong Guan. TheBoard is of the opinion that it is not necessary to separate the roles of the Chairman and the Chief Executive Officer after taking into account the current size, scope and the nature of the operations of the Company, and with the strong presence of Independent Directors on the Board. The Board is of the view that there are sufficient safeguards and checks to ensure that the process of decision making by the Board is independent and based on collective decisions without any individual or group of individuals exercising any considerable concentration of power or influence and there is accountability for good corporate governance. There is an appropriate balance of power and authority given that the majority of the members (including the respective Chairmen) of the Board Committees are independent and the Board Committees are chaired by Independent Directors. Taking into account the above, the Board is of the view that the Company complies with Principle 3 of the Code.

Provision 3.2

Role of Chairman and Chief Executive Officer

As Executive Chairman of the Board, Mr Tan Tong Guan leads the Board and is responsible for the management of the Board. When setting the agenda, he ensures that adequate time is available for discussion of all agenda items, in particular strategic matters. The Executive Chairman encourages Board’s interaction with the Management, facilitates effective contribution of the Non-Independent and Non-Executive Director and Independent Directors,encourages constructive relations among the Directors and promotes high standards of corporate governance. In addition, the Executive Chairman ensures that the Directors receive accurate, timely and clear information and there is effective communication with Shareholders and other stakeholders.

The Executive Chairman, being the Chief Executive Officer, is also in charge of charting the business direction as well as corporate planning and strategic developments of the Company and the Group.

Provision 3.3

Lead Independent Director 

As the roles of the Chairman and the Chief Executive Officer are held by the same person, Mr Henry Tan Song Kok has been appointed as the Lead Independent Director of the Company as recommended by the Code, to provide leadership in situations where the Chairman, who is not independent, is conflicted. As the Lead Independent Director, Mr Henry Tan Song Kok is available to address the concerns of Shareholders and when contact through the normal channels of communication to the Executive Chairman and Chief Executive Officer or the Chief Financial Officer has failed to satisfactorily resolve their concerns or when such contact is inappropriate or inadequate.

The Non-Independent and Non-Executive Director and Independent Directors are encouraged to meet periodically without the presence of the Management where necessary. The Lead Independent Director will also provide feedback to the Chairman after such meetings.

There were no query or request on any matters which requires the Lead Independent Director’s attention received in FY2023.

Principle 4: Board Membership

The Board has a formal and transparent process for the appointment and re-appointment of directors, taking into account the need for progressive renewal of the Board.

Provisions 4.1 and 4.2

Nominating Committee Composition

The Nominating Committee comprises the following members, all of whom are non-executive and the majority, including the Chairman, are independent:

Kim Seah Teck Kim (Independent Director)                                               Chairman 

Henry Tan Song Kok (Lead Independent Director)                                 Member

Tan Geok Moey (Non-Independent and Non-Executive Director)    Member 

 

Roles and Duties of Nominating Committee 

The Nominating Committee has written terms of reference that sets out its duties and responsibilities. Amongst them, the Nominating Committee is responsible for:

  • reviewing board succession plans for Directors, in particular, the appointment and/or replacement of the Chairman and the Chief Executive Officer, and key management personnel;
  • creating a formal and transparent process for the appointments and re-nominations of members of the Board and to evaluate the performance of the Board as a whole, its Board Committees and the contribution of individual Directors to the effectiveness of the Board;
  • affirming annually the independence of the Directors;
  • the appointment and re-appointment of directors (if any); and
  • reviewing training and professional development programs for the Board.

The Nominating Committee is scheduled to meet at least once a year. Each member of the Nominating Committee shall abstain from voting on any resolution in respect of the evaluation of his/her performance or re-nomination as a Director.

Provision 4.3

Nomination and Selection of Directors

For new appointments to the Board, the Nominating Committee will consider the Company’s current Board size and its composition and decide if the candidate’s background, experience, expertise and knowledge will complement the skills and competencies of the existing Directors on the Board. The candidate must be a person of integrity and must be able to commit sufficient time and attention to the affairs of the Company, especially if he is serving on multiple boards. The Nominating Committee will ensure that new Directors are aware of their duties and obligations. In addition, the Nominating Committee will take into consideration whether a candidate had previously served on the board of a company with an adverse track record or a history of irregularities, or whether the candidate is or was under investigation by professional associations or regulatory authorities. The Nominating Committee will also assess whether a candidate’s resignation from the board of any such company would cast any doubt on the candidate’s qualification and ability to act as a Director of the Company.

If a vacancy arises under any circumstances, or where it is considered that the Board would benefit from the services of a new Director, the Nominating Committee, in consultation with the Board, will determine the selection criteria and select the appropriate candidate for the position. The search for a suitable candidate is drawn from the contacts and networks of existing Directors. The Nominating Committee can also approach relevant institutions such as the Singapore Institute of Directors, professional organisations or business federations to source for a suitable candidate..

Re-election of Directors

In accordance with the Code and Rule 720(4) of the Catalist Rules, all Directors shall submit themselves for re-nomination and re-election at least once every three (3) years. Pursuant to Regulation 95 of the Company’s Constitution, at least one-third of the Directors will retire at the annual general meeting (“AGM”) each year. In addition, Regulation 101 of the Company’s Constitution provides that a newly appointed Director can only hold office until the next AGM and then be eligible for re-election but shall not be taken into account in determining the number of Directors who are to retire by rotation. The Nominating Committee is charged with the responsibility of re-nomination having regard to the Director’s contribution and performance (e.g. attendance, preparedness, participation and candour) including, if applicable, as an Independent Director

The Nominating Committee has recommended to the Board that Mr Tan Tong Guan and Mr Kim Seah Teck Kim (collectively the “Retiring Directors”) be nominated for re-election at the upcoming AGM. In making the recommendation, the Nominating Committee had considered, among others, each of the Retiring Directors’ contribution and performance to the Board and the Group. Mr Kim Seah Teck Kim, being a member of the Nominating Committee, has abstained from making any recommendation and/or participating in any deliberation of the Nominating Committee in respect of the assessment of his own re-election as a Director of the Company.

Mr Tan Tong Guan will, upon re-election as a Director, remain as the Executive Chairman and Chief Executive Officer.

Mr Kim Seah Teck Kim will, upon re-election as a Director, remain as an Independent Director, Chairman of the Nominating Committee and the Remuneration Committee as well as a member of the Audit Committee. Mr Kim Seah Teck Kim is considered by the Board to be independent for the purpose of Rule 704(7) of the Catalist Rules.

Details of the Retiring Directors seeking for re-election at the upcoming AGM are set out on pages 72 to 77 of the Annual Report in compliance with the Rule 720(5) of the Catalist Rules.

Provision 4.4

Review of Directors’ Independence

As set out under Provision 2.1 of the Code above, on an annual basis, the Nominating Committee is required to determine the independence status of the Directors, bearing in mind the circumstances set forth in the Code, Rule 406(3)(d) of the Catalist Rules and any other salient factors. The Independent Directors have submitted their respective confirmation of independence annually for the Nominating Committee’s review. For FY2023, the Nominating Committee has reviewed the confirmation of independence submitted by the Independent Directors and determined that the Independent Directors (namely Mr Kim Seah Teck Kim and Mr Henry Tan Song Kok) are independent. Each of the Independent Directors, being members of the Nominating Committee, has abstained and not participated in the review and determination in respect of himself.

Currently, there is no alternate Director on the Board. 

Provision 4.5

Directors’ Time Commitments

The Nominating Committee ensures that new Directors are aware of their duties and obligations. For re-nomination and re-appointment of Directors, the Nominating Committee takes into consideration the competing time commitments faced by Directors and their ability to devote appropriate time and attention to the Group.

Please refer to the section entitled “Directors Profile” of the Annual Report for the listed company directorship and principal commitments of each Director.

As set out under Provision 1.5 of the Code above, the Nominating Committee has reviewed and is of the opinionthat the Directors are able to and have adequately carried out their duties as Directors of the Company, as well as sufficient time and attention are given by the Directors to the affairs of the Company, in FY2023. Each of the Independent Directors, being members of the Nominating Committee, has abstained and not participated in the review and determination in respect of himself.

Principle 5: Board Performance

The Board undertakes a formal annual assessment of its effectiveness as a whole, and that of each of its Board Committees and individual Directors.

Provisions 5.1 and 5.2

The Board and the Nominating Committee strive to ensure that Directors on the Board possess the experience, knowledge and skills critical to the Company’s business so as to enable the Board to make sound and well-considered decisions.

The Nominating Committee had carried out an annual performance evaluation process to assess the effectiveness of the Board as a whole and its Board Committees. The purpose of the evaluation process is to increase the overall effectiveness of the Board and its Board Committees. Each Director completes an evaluation form to assess the overall effectiveness of the Board as a whole and its Board Committees. The appraisal process for the Board focuses on the evaluation of factors such as the composition of the Board, the Board’s accessibility to information, Board procedures and accountability, communication with key management personnel and Directors’ standards of conduct. The appraisal process for the Board Committees, on the other hand, focused on the evaluation of the respective Board Committees structure, conduct of meetings, measurement and monitoring of Board Committees performance. The results of these evaluations are reviewed and used constructively by the Nominating Committee to identify areas of improvements and recommending appropriate course of action to the Board. Based on the results collated from the evaluations, the Nominating Committee is of the view that the overall effectiveness of the Board as a whole and the Board Committees has been satisfactory for FY2023.

The Nominating Committee had decided unanimously, that the Directors will not be evaluated individually as it is more appropriate and effective to assess the overall effectiveness of the Board as a whole, bearing in mind that each Director contributes in different ways to the success of the Company and Board decisions are made collectively. In addition, the factors taken into consideration for each Director’s re-nomination are the extent of his/her attendance, participation and contribution in the proceedings of the meetings.

For FY2023, the Nominating Committee has not engaged any external facilitator to assist in the assessment of the effectiveness of the Board as a whole and the Board Committees. Where relevant, the Nominating Committee will consider such engagement.

Principle 6: Procedures for Developing Remuneration Policies

The Board has a formal and transparent procedure for developing policies on Director and executive remuneration, and for fixing the remuneration packages of individual Directors and key management personnel. No Director is involved in deciding his or her own remuneration.

Provisions 6.1, 6.2 and 6.3

Remuneration Committee Composition

The Remuneration Committee comprises the following members, all of whom are non-executive and the majority, including the Chairman, are independent:

Kim Seah Teck Kim (Independent Director)                                               Chairman 

Henry Tan Song Kok (Lead Independent Director)                                 Member

Tan Geok Moey (Non-Independent and Non-Executive Director)    Member 

Roles and Duties of Remuneration Committee and Remuneration Framework

The Remuneration Committee has written terms of reference that sets out its duties and responsibilities. Amongst them, the Remuneration Committee is responsible for:

  • recommending to the Board a general framework of remuneration for the Directors and key management personnel, and determine specific remuneration packages for each Director as well as for key management personnel, and the recommendations of the Remuneration Committee are submitted for endorsement by the entire Board. All aspects of remuneration, including but not limited to Directors’ and key management personnel’s fees, salaries, allowances, bonuses, options, share-based incentives and awards, and benefits-in-kind will be covered by the Remuneration Committee; and

     

  • performing an annual review of the remuneration of employees related to the Directors and substantial Shareholders to ensure that their remuneration packages are in line with the Company’s staff remuneration guidelines and commensurate with their respective job scope and level of responsibilities. It will also review and approve any bonuses, pay increases and/or promotions for these employees.

The Remuneration Committee will also review the Company’s obligations under the service agreements entered into with the Executive Chairman and Chief Executive Officer, and key management personnel that would arise in the event of termination of these service agreements. This is to ensure that such service agreements contain fair and reasonable termination clauses which are not overly generous. The Remuneration Committee aims to be fair and avoid rewarding poor performance.

The Remuneration Committee is scheduled to meet at least once a year. Each member of the Remuneration Committee shall abstain from voting on any resolution in respect of his/her remuneration package or that of employees related to him/her.

Provision 6.4

Engagement of Remuneration Consultants

The Remuneration Committee, if necessary, may seek external expert advice of which the expenses will be borne by the Company. For FY2023, the Remuneration Committee has not sought external advice nor appointed remuneration consultants in considering the remuneration of all Directors.

Principle 7: Level and Mix of Remuneration

The level and structure of remuneration of the Board and key management personnel are appropriate and proportionate to the sustained performance and value creation of the Company, taking into account the strategic objectives of the Company.

Provisions 7.1 and 7.3

As part of its review, the Remuneration Committee ensures that remuneration packages of the Directors and key management personnel are comparable within the industry and with similar companies. The Remuneration Committee considers the Company’s relative performance and the contributions and responsibilities of the individual Directors.

Policy in respect of Executive Director’s and other key management personnel’s remuneration

The Company advocates a performance-based remuneration system that is flexible and responsive to the market, and takes into consideration the Company’s and the individual employee’s performance. The total remuneration mix comprises annual fixed cash and annual performance incentive. The annual fixed cash component comprises the annual basic salary plus any other fixed allowances. The Company believes in promoting commitment and motivation by aligning incentives with performance, so as to be able to attract, retain and motivate talents without being excessive, and thereby maximise value for Shareholders.

The Company currently does not have any long-term incentive scheme.

The Executive Chairman and Chief Executive Officer does not receive Director’s fees, and is paid pursuant to his service agreement.

The Company’s wholly-owned subsidiary, AVH Animal Ark Pte. Ltd., has also entered into a service agreement with Dr Joyce Lauw Shi Yu (“Dr Joyce Lauw”) (a key management personnel of the Group). Dr Joyce Lauw will be paid a monthly remuneration, to be reviewed from time to time by the Remuneration Committee, and a discretionary bonus of such amount and at such intervals as AVH Animal Ark Pte. Ltd. may in its absolute discretion determine. The service agreement also provides for, inter alia, use of intellectual property, certain restrictive covenants (including non-compete obligation), and grounds of termination. Having considered the market practice, the Remuneration Committee and the Board had discussed and decided to reduce the notice of termination of Dr Joyce Lauw to three (3) months with effect from 1 January 2023. In view of this, AVH Animal Ark Pte. Ltd. has the right to terminate Dr Joyce Lauw’s employment with immediate effect, or either party may terminate the employment by giving the other three (3) months’ notice in writing, and only AVH Animal Ark Pte. Ltd. may pay salary in lieu of the required period of notice.

Having reviewed and considered the variable components in the remuneration packages of the Executive Chairman and Chief Executive Officer, and key management personnel, the Remuneration Committee is of the view that there is presently no urgent need for the Company to consider the use of contractual provisions to allow the Company to reclaim incentive components of remuneration from Executive Chairman and Chief Executive Officer, and key management personnel in exceptional circumstances of misstatement of financial results or misconduct resulting in financial loss to the Company.

Provision 7.2

Policy in respect of remuneration for Non-Executive Directors

The Non-Independent and Non-Executive Director, and the Independent Directors do not have service agreements with the Company. They are compensated based on fixed Directors’ fees, which are determined by the Board, after the recommendation by the Remuneration Committee, based on their contribution, taking into consideration factors such as effort, time spent and responsibilities of the Non-Independent and Non-Executive Director, and the Independent Directors. The Chairman of each Board Committee is paid an additional fee, and the Chairman of Audit Committee is paid a higher fee than the Chairman of the other Board Committees in view of the higher responsibility carried by that office. The proposed Directors’ fees are subject to approval by Shareholders at the AGM. Save for the Directors’ fees, the Non-Independent and Non-Executive Director, and the Independent Directors do not receive any other remuneration from the Company.

Principle 8: Disclosure on Remuneration

The Company is transparent on its remuneration policies, level and mix of remuneration, the procedure for setting remuneration, and the relationships between remuneration, performance and value creation.

Provisions 8.1 and 8.3

Remuneration Policy and Criteria

As set out under Provisions 7.1 and 7.3 of the Code above, the Company advocates a performance-based remuneration system that is flexible and responsive to the market, which takes into consideration the Company’s and the individual employee’s performance. The total remuneration mix comprises annual fixed cash and annual performance incentive. The annual fixed cash component comprises the annual basic salary plus any other fixed allowances.

Remuneration of Directors and key management personnel

The level and mix of remuneration of the Company’s Directors and key management personnel (who are not Directors or the Chief Executive Officer) for FY2023 are as follows:

Remuneration band and Name of Director 

Base/Fixed salary*

(%)

Bonus

(%)

Directors’ fees**

(%)

Benefits-in-kind

(%)

Total

(%)

   

Directors

             

Between S$250,000 and S$500,000

             

Tan Tong Guan

84

16

100

   
               

Below S$250,000

             

Tan Geok Moey

100

100

   

Kim Seah Teck Kim

100

100

   

Henry Tan Song Kok

100

100

   

 

 

 

 

Remuneration band and 

Name of Key Management Personnel*** 

Base/Fixed salary*

(%)

Bonus

(%)

Benefits-in-kind

(%)

Total

(%)

Below S$250,000

       

Xue Ru

80

20

100

Joyce Lauw Shi Yu

99

1

100

 


*                These amounts are inclusive of employer’s Central Provident Fund (“CPF”) contribution.
**              The proposed Directors’ fees for FY2023 is subject to Shareholders’ approval at the forthcoming AGM.
***           The Group has only two (2) key management personnel (who are not Directors or the Chief Executive Officer) during FY2023.

The Board believes that it is for the benefit of the Company not to disclose in absolute number and in aggregate, the remuneration breakdown of the Directors as well as the aggregate of the total remuneration paid to the key management personnel (who are not Directors or the Chief Executive Officer), due to its sensitive nature and concerns of poaching. After taking into account the reasons for non-disclosure stated above, the Board is of the view that the current disclosure of the remuneration presented herein in this report is sufficient to provide Shareholders information on the Group’s remuneration policies, as well as the level and mix of remuneration. Accordingly, the Board is of the view that the Company complies with Principle 8 of the Code.

The Company currently does not have an employee share option scheme or performance share plan in place.

None of the Directors (including the Executive Chairman and Chief Executive Officer) and the key management personnel (who are not Directors or the Chief Executive Officer) of the Company has received any termination, retirement or post-employment benefits for FY2023.

The Board has not included a separate annual remuneration report to Shareholders in the Annual Report on the remuneration of the Directors and the key management personnel (who are not Directors or the Chief Executive Officer) as the Board is of the view that the matters which are required to be disclosed in such annual remuneration report have already been sufficiently disclosed in the Annual Report and in the financial statements of the Company.

Provision 8.2

Remuneration of Substantial Shareholder or Immediate Family Members of Director and Chief Executive Officer

Save for the Executive Chairman and Chief Executive Officer, there is no employee of the Company who is also a substantial Shareholder, or is an immediate family member of any Director, the Executive Chairman and Chief Executive Officer or a substantial Shareholder, and whose remuneration exceeded $100,000 during FY2023. “Immediate family member” refers to the person’s spouse, child, adopted child, step-child, sibling and parent.

Principle 9: Risk Management and Internal Controls

The Board is responsible for the governance of risk and ensures that Management maintains a sound system of risk management and internal controls, to safeguard the interests of the Company and its Shareholders.

Provisions 9.1 and 9.2

The Company has established an enterprise risk management framework and register to identify, manage and monitor the business and operating risks impacting the Group on an on-going basis. The Board has overall responsibility for the governance of risk and with the support of the Audit Committee, oversees the design, implementation and monitoring of the risk management and internal control systems.

The Audit Committee will review the reports submitted by the independent internal auditors relating to the adequacy and effectiveness of the Group’s significant internal controls (including financial, operational, compliance and information technology controls) and risk management systems. The Audit Committee will also review the effectiveness of the actions taken by the Management on the recommendations made by the independent internal auditors in this respect.

On an annual basis, the Board will review the adequacy and effectiveness of the internal controls (including financial, operational, compliance and information technology controls) and risk management systems to ensure that they are able to meet the needs of the Group in its current business environment.

For FY2023, the Board has received assurance (i) from the Executive Chairman and Chief Executive Officer, and the Chief Financial Officer that the financial records have been properly maintained and the financial statements give a true and fair view of the Company’s operations and finances; and (ii) from the Executive Chairman and Chief Executive Officer, and other key management personnel that the Company’s risk management and internal control systems are effective and adequate.

The Board and the Audit Committee have reviewed the adequacy and effectiveness of the Group’s internal controls (including financial, operational, compliance and information technology controls) and risk management systems in all material aspects. As part of the annual statutory audit of the financial statements, the external auditors will highlight any material weaknesses in financial controls over the areas that are significant to the audit. Such material internal control weaknesses noted during their audit and recommendations, if any, by the external auditors are reported to the Audit Committee. The Audit Committee will follow up on the actions taken by the Management in response to the recommendations made by the external auditors. The Audit Committee has also reviewed the follow up reports submitted by the independent internal auditors and reviewed the effectiveness of the actions taken by the Management on the recommendations made by the independent internal auditors in this respect.

Based on the internal controls established and maintained by the Group, work performed by the independent internal auditors and the external auditors, reviews performed by the Management and assurance received from the Executive Chairman and Chief Executive Officer, the Chief Financial Officer and other key management personnel, the Board, with the concurrence of the Audit Committee, is of the opinion that the Group’s internal controls (including financial, operational, compliance and information technology controls) and risk management systems are adequate and effective for FY2023.

The Board will consider the necessity of establishing a separate Board risk committee as and when it deems necessary.

The Board and the Audit Committee note that all internal control systems contain inherent limitations and no systems of internal controls could provide absolute assurance against the occurrence of material errors, poor judgement in decision making, human errors, losses, fraud or other irregularities.

Principle 10: Audit Committee

The Board has an Audit Committee which discharges its duties objectively.

Provisions 10.2 and 10.3

Audit Committee Composition

The Audit Committee comprises the following members, all of whom are non-executive and the majority, including the Chairman, are independent:

Henry Tan Song Kok (Lead Independent Director)                                 Chairman

Tan Geok Moey (Non-Independent and Non-Executive Director)    Member 

Kim Seah Teck Kim (Independent Director)                                               Member

At least two (2) members of the Audit Committee have accounting and related financial management expertise and experience. None of the members of the Audit Committee is a former partner or director of the Company’s existing audit firm (a) within a period of two years commencing on the date of his/her ceasing to be a partner of the audit firm and (b) for as long as he/she has any financial interest in the auditing firm.

Provision 10.1 

Roles and Duties of Audit Committee 

The Audit Committee has explicit authority to investigate any matter within its terms of reference, full access to and co-operation by the Management, full discretion to invite any person including Director or key management personnel of the Company to attend its meetings, and reasonable resources to enable it to discharge its functions properly. The Audit Committee will assist the Board in discharging its responsibility to safeguard the assets of the Company, maintain adequate accounting records, and develop and maintain effective systems of internal control, with the overall objective of ensuring that the Management creates and maintains adequate and effective control environment in the Company. The Audit Committee will provide a channel of communication between the Board, the Management and the external auditors on matters relating to audit.

The Audit Committee has written terms of reference that sets out its duties and responsibilities. Amongst them, the Audit Committee is responsible for:

  • reviewing the scope and results of the audit and its cost effectiveness;

     

  • reviewing the significant financial reporting issues and judgements so as to ensure the integrity of the financial statements of the Company and any announcements relating to the Company’s financial performance where the external auditors in their review or audit of the Company’s year-end financial statements, raise any significant issues which have a material impact on the interim financial statements or financial results previously announced by the Company;

     

  • reviewing and assisting the Board to improve the quality of interim financial statements or financial updates;

     

  • making recommendations to the Board on the appointment, re-appointment and removal of the external auditors, and approving the remuneration and terms of engagement of the external auditors;

     

  • reviewing with the external auditors the audit plan, their evaluation of the system of internal accounting controls, their letter to the Management and the Management’s response;

     

  • reviewing the half year and annual financial statements and results announcements before submission to the Board for approval, focusing in particular on changes in accounting policies and practices, major risk areas, significant adjustments resulting from the audit, compliance with accounting standards and compliance with the Catalist Rules and any other relevant statutory or regulatory requirements;

     

  • reviewing annually the adequacy and effectiveness of the Company’s internal controls (including financial, operational, compliance and information technology controls), as well as risk management policies and systems established by the Management. The Audit Committee will also ensure co-ordination between the external auditors and the Management, and review the assistance given by the Management to the external auditors, and discuss problems and concerns, if any, arising from audits, and any matters which the external auditors may wish to discuss (in the absence of the Management, where necessary);

     

  • reviewing and discussing with the external auditors any suspected fraud or irregularity, or suspected infringement of any relevant laws, rules or regulations, which have or are likely to have a material impact on the Company’s operating results or financial position, and the Management’s response;

     

  • reviewing interested person transactions (if any) falling within the scope of Chapter 9 of the Catalist Rules;

     

  • reviewing potential conflicts of interest (if any);

     

  • reviewing with the internal auditor, their internal audit plans and their evaluation of the adequacy and effectiveness of the internal control and accounting system before submission of the results of such review to the Board for approval;

     

  • reviewing the independence, adequacy of resources and effectiveness of the internal audit function and whether the internal audit function has the appropriate standing within the Group, on an annual basis;

     

  • reviewing and establishing procedures for receipt, retention and treatment of complaints received by the Company regarding, inter alia, criminal offences involving the Company or its employees, questionable accounting, auditing, business, safety or other matters that impact negatively on the Company;

     

  • reviewing key financial risk areas, with a view to providing an independent oversight on the Company’s financial reporting, the outcome of such review to be disclosed in the annual report or, where the findings are material, announced immediately via SGXNet;

     

  • reviewing the Company’s compliance with relevant government regulations and licensing requirements;

     

  • undertaking such other reviews and projects as may be requested by the Board, and reporting to the Board its findings from time to time on matters arising and requiring the attention of the Audit Committee; and

     

  • generally, undertaking such other functions and duties as may be required by statute or by the Catalist Rules, or by such amendments as may be made thereto from time to time.

The Audit Committee shall also commission and review the findings of internal investigations into matters where there is any suspected fraud or irregularity, or failure of internal controls or infringement of any Singapore law, rule or regulation which has or is likely to have a material impact on the operating results and/or financial position of the Company. In the event that a member of the Audit Committee is interested in any matter being considered by the Audit Committee, he/she will abstain from reviewing that particular transaction or voting on that particular resolution.

Provision 10.4

Internal Audit Function

The current size of the operations of the Group does not warrant the Group to have an in-house audit function. The internal audit function of the Group has been outsourced to In.Corp Business Advisory Pte. Ltd., an independent accounting and auditing firm.

The internal auditor’s primary line of reporting is to the Chairman of the Audit Committee. The Audit Committee will review the internal audit plan to ensure that the scope is adequate and covers the review of the significant business functions of the Group and all internal audit findings and recommendations are submitted to the Audit Committee for deliberation with copies of these reports extended to the relevant key management executives. The Audit Committee approves the appointment, termination, evaluation and fees of the internal audit firm.

The internal auditor is guided by the International Standards for the Professional Practice of Internal Auditing issued by the Institute of Internal Auditors.

The Company cooperates fully with the internal auditor in terms of allowing unfettered access to all the Company’s documents, records, properties and personnel, including access to the Audit Committee.

The Audit Committee has reviewed with the internal auditors their audit plan and their evaluation of the system of internal controls and has evaluated their audit findings and Management’s responses to those findings, the adequacy and effectiveness of material internal controls, (including financial, operational, compliance and information technology controls) and risk management systems of the Company and the Group for FY2023. The Audit Committee is satisfied that In.Corp Business Advisory Pte. Ltd. is independent, adequately resourced and effective, and has the appropriate standing within the Group. The Audit Committee is also of the view that In.Corp Business Advisory Pte. Ltd. is adequately staffed with persons with relevant qualifications and experience and adheres to professional standards including those promulgated by The Institute of Internal Auditors.

The Audit Committee will annually, review the independence, adequacy of resources and effectiveness of the internal audit function and ensure that it has appropriate standing within the Group.

External Audit Function

The Audit Committee will review the independence and objectivity of external auditors annually after taking into account all audit and non-audit services provided to the Company. Having considered the breakdown of fees paid to the external auditors as detailed on page 71 of the Annual Report and compliance with Singapore Accountants (Public Accountants) Rules, as well as the nature and extent of such services, the Audit Committee is satisfied that such services will not prejudice the independence and objectivity of the external auditors. The external auditors have also confirmed their independence in this respect, and that they are registered with the Accounting and Corporate Regulatory Authority and approved under the Accountants Act 2004 of Singapore. The audit partner-in-charge assigned to the audit is a registered public accountant under the Accountants Act 2004 of Singapore.

After considering the adequacy of the resources and experience of the external auditors’ firm and the audit partner-in-charge assigned to the audit, the firm’s other audit engagements, the size and complexity of the Group and the number and experience of supervisory and professional staff assigned to the particular audit as well as the standard and quality of work performed by Ernst & Young LLP for past financial years, the Audit Committee is satisfied with and has recommended to the Board the nomination and re-appointment of Ernst & Young LLP as the external auditors for the Company’s audit obligations for the financial year ending 31 December 2024, at the forthcoming AGM.

In appointing the auditing firms for the Company and its subsidiaries, the Company has complied with Rules 712 and 715 of the Catalist Rules for FY2023.

Provision 10.5

Meeting Auditors without the Management

In performing its functions, the Audit Committee and Management meet with the external and internal auditors to discuss and evaluate the internal controls of the Group and review the overall scope of both external and internal audits. At least once a year and as and when required, the Audit Committee meets with the external and internal auditors without the presence of Management, to review any matters that might be raised privately.

For FY2023, the Audit Committee has met with the external auditors and the internal auditors once, without the presence of the Management.

Key Audit Matters

The Audit Committee is kept abreast by the external auditors on regulatory changes and updated accounting standards during the Audit Committee meetings.

The Audit Committee has reviewed the key audit matters disclosed in the external auditors’ report and is of the view that there is no material inconsistency between the audit procedures adopted by the external auditors and the Management’s assessment.

Whistle Blowing Policy

The Company has put in place a whistleblowing policy, whereby anyone may, in good faith and in confidence, raise concerns or observations about possible corporate malpractices and improprieties in financial reporting or other matters directly to Mr Henry Tan Song Kok, the Lead Independent Director and Chairman of the Audit Committee. The policy sets out procedures for a whistleblower to make a report to the Company on misconduct or wrong doing relating to the Company and its officers.

The Audit Committee is responsible for oversight and monitoring of whistleblowing and will review the policy and arrangements by which staff of the Group may, in confidence, raise concerns about possible improprieties in matters of financial reporting or other matters. The objective of the Audit Committee will be to ensure that arrangements are in place for the independent investigation of such matters and for appropriate follow-up actions.

The Group will take all reasonable steps to protect the identity of the whistleblower so as to ensure that the identity of the whistleblower is kept confidential – subject to legal or regulatory requirements. All information disclosed during the course of investigation will remain confidential, except as necessary or appropriate to conduct the investigation and to take any remedial action, in accordance with any applicable laws and regulations. The Group prohibits discrimination, retaliation or harassment of any kind against a whistleblower who submits a complaint or report in good faith.

No such whistleblowing report was received and no such matter was raised by any staff of the Group for FY2023.

Audit Committee Activities

In FY2023, the Audit Committee had, among others, carried out the following activities:

  1. reviewed the half-year and full-year financial statements announcements of the Group, and recommended to the Board for approval and release via the SGXNet;

     

  2. reviewed the adequacy and effectiveness of the Group’s internal controls (including financial, operations, compliance and information technology controls), and risk management systems;

     

  3. reviewed and approved the audit plan of the internal auditors;

     

  4. reviewed the independence, adequacy of resources and effectiveness of the internal auditors and whether the internal auditors have the appropriate standing within the Group;

     

  5. reviewed and approved the annual audit plan of the external auditors;

     

  6. reviewed the independence of the external auditors;

     

  7. reviewed the annual re-appointment of the external auditors and determined their remuneration, and made a recommendation for the Board’s approval; and

     

  8. met with the external auditors and internal auditors once without the presence of the Management.

Principle 11: Shareholder Rights and Conduct of General Meetings

The Company treats all Shareholders fairly and equitably in order to enable them to exercise Shareholders’ rights and have the opportunity to communicate their views on matters affecting the company. The Company gives Shareholders a balanced and understandable assessment of its performance, position and prospects.

Provisions 11.1, 11.2, 11.3 and 11.4

All Shareholders are informed of Shareholders’ meetings through notices contained in annual reports or circulars sent to all Shareholders. These notices are also published in the newspapers and posted onto SGXNet and the Company’s corporate website. Shareholders are encouraged to attend the Company’s general meetings and to participate effectively in and vote at general meetings of Shareholders to ensure a high level of accountability and to stay informed of the Company’s strategies and growth plans and establish and maintain regular dialogue between the Company and Shareholders, to gather views and inputs, and address Shareholders’ concerns. The chairpersons and/or members of the Board, the Audit Committee, the Remuneration Committee and the Nominating Committee, as well as the external auditors are normally available at Shareholders’ meetings to address any Shareholders’ queries, including those relating to the conduct of audit and the preparation and content of the auditors’ report. All Directors, the Management, the company secretary, the external auditors and the Company’s continuing sponsor were present at the 2023 AGM. Save for the 2023 AGM, there were no other general meetings of the Company held during FY2023.

If any Shareholder is unable to attend, he/she is allowed to appoint up to two (2) proxies to vote on his/her behalf at the meeting through proxy forms sent in advance. The Company’s Constitution currently does not allow a member to appoint more than two (2) proxies to attend and vote at the same general meetings and for other absentia voting methods such as by mail, electronic mail, fax and/or other methods. With effect from 3 January 2016, the Companies Act 1967 of Singapore was amended, amongst others, to allow certain members, defined as “relevant intermediary” to attend and participate in general meetings. Relevant intermediary includes corporations holding licences in providing nominee and custodial services and CPF Board which purchases shares on behalf of the CPF investors.

The Company’s last AGM held on 26 April 2023 (“2023 AGM”) was held, in a wholly physical format, pursuant to the COVID-19 (Temporary Measures) (Alternative Arrangements for Meetings for Companies, Variable Capital Companies, Business Trusts, Unit Trusts and Debenture Holders) Order 2020 (“COVID-19 Order”). The notice of the 2023 AGM was not published in the newspaper, but was instead disseminated to Shareholders through publication on SGXNet and the Company’s corporate website, in accordance with the alternative arrangements for holding of general meetings pursuant to the COVID-19 Order.

Shareholders participated in the 2023 AGM, voting by appointing their proxies or the Chairman of the 2023 AGM as proxy and their questions (if any) in relation to any resolution set out in the notice of the 2023 AGM were to be sent to the Company in advance of the 2023 AGM, and responses to substantial and relevant questions were to be provided via announcement on SGXNet and the Company’s corporate website. The Company did not receive any question from Shareholders before the 2023 AGM.

Each item of special business included in the notice of the general meetings will be accompanied by full explanation of the effects of a proposed resolution. Separate resolutions are proposed for each substantially separate issue at general meetings.

Each item of special business included in the notice of the general meetings will be accompanied by full explanation of the effects of a proposed resolution. Separate resolutions are proposed for each substantially separate issue at general meetings.

The forthcoming AGM in respect of FY2023 will be convened in a wholly physical format and there will be no option for Shareholders to participate virtually. Please refer to the notice of forthcoming AGM dated 9 April 2024 as set out in this Annual Report for more information on how Shareholders may participate in the forthcoming AGM.

Pursuant to Rule 730A(2) of the Catalist Rules, all resolutions proposed at the AGM and at any adjournment thereof shall be put to the vote by way of poll. All shareholders are entitled to vote in accordance with the established voting rules and procedures at the AGM. Each share is entitled to one vote. An external firm is appointed as scrutineers for the AGM voting process. The detailed results setting out the number of votes cast for and against each resolution and the respective percentages are announced via SGXNet after the AGM.

Provision 11.5

Minutes of General Meetings

The Company prepares minutes of general meetings that include substantial and relevant comments or queries from Shareholders relating to the agenda of the meeting, and responses from the Board and the Management. Minutes of the 2023 AGM had been published by the Company on its corporate website and SGXNet within one (1) month from the date of the 2023 AGM.

Provision 11.6

Dividend Policy

The Company does not have a policy on payment of dividends. The issue of payment of dividend is deliberated by the Board annually having regard to various factors such as cash position, business prospects and capital commitments. The Company has not declared any dividend for FY2023 as the Board deems it appropriate to conserve cash for the Group’s business activities and growth.

Principle 12: Engagement with Shareholders

The Company communicates regularly with its Shareholders and facilitates the participation of Shareholders during general meetings and other dialogues to allow Shareholders to communicate their views on various matters affecting the Company.

Provisions 12.1, 12.2 and 12.3

The Board believes in regular, timely and effective communication with Shareholders. Shareholders are kept informed of all important developments concerning the Company through timely dissemination of information via SGXNet announcements, press releases, annual reports and various other announcements made whenever necessary.

The Company will voluntarily announce interim updates on useful and relevant information in addition to the mandatory financial statements to provide Shareholders a better understanding of the Company’s performance. The Board will consider whether interim updates should be provided to Shareholders, and the appropriate frequency of the updates.

The AGM is the principal forum for dialogue between the Company and Shareholders, to gather views and inputs, and address Shareholders’ concerns. The Company recognises the value of feedback from Shareholders. During the general meetings, Shareholders are given ample time and opportunities to air their views and concerns. All the Directors will endeavour to attend the general meetings, and Shareholders will be given the chance to share their thoughts and ideas or ask questions relating to the resolutions to be passed or on other corporate and business issues. Please refer to Principle 11 above for information on the proceedings of the 2023 AGM held in FY2023.

Presently, the Company does not have an investor relations policy or protocol in place nor a dedicated investor relations team. However, the Board’s policy is that all Shareholders should be informed simultaneously in an accurate and comprehensive manner regarding all material developments that impact the Group via SGXNet on an immediate basis, in line with the Group’s disclosure obligations pursuant to the Catalist Rules and the Companies Act 1967 of Singapore. There is no dedicated investor relations team in place as the Board is of the view that the current communication channels are sufficient and cost-effective. The Company will assess the need to establish an investor policy or protocol or investor relations team as and when it deems necessary. Notwithstanding so, taking into account the communication and dialogue with Shareholders undertaken by the Company as set out above, the Board is of the view that the Company complies with Principle 12 of the Code.

Principle 13: Engagement with Stakeholders

The Board adopts an inclusive approach by considering and balancing the needs and interests of material stakeholders, as part of its overall responsibility to ensure that the best interests of the Company are served.

Provisions 13.1 and 13.2

Stakeholders’ Engagement

The Group has regularly engaged its stakeholders through various medium and channels to ensure that the business interests are aligned with those of the stakeholders, to understand and address the concerns so as to improve services and products’ standards, as well as to sustain business operations for long-term growth.

The stakeholders have been identified as those who are impacted by the Group’s business and operations and those who are similarly are able to impact the Group’s business and operations. They are namely, employees, customers, suppliers, investors and regulators. The Group has also undertaken a process to determine the economic, environmental, social and governance issues, which are important to these stakeholders. These issues form the materiality matrix upon which targets, performance and progress are reviewed and endorsed by the Board annually.

Please refer to the sustainability report for FY2023 set out on pages 10 to 46 of this Annual Report for the details of the stakeholder engagement and materiality assessment.

Provision 13.3

Corporate Website

The Company maintains a corporate website at http://asiavets.com to communicate and engage with stakeholders. The corporate website provides, among others, announcements, annual reports, sustainability reports, and financial information of the Group, stock information of the Company, as well as the profiles of the Group, the Directors and the key management personnel.

Dealings in Securities

The Company observes closely the best practices on dealings in securities (“Securities Dealings Best Practices”) in compliance with Rule 1204(19) of the Catalist Rules. The Securities Dealings Best Practices provide guidance to Directors and employees of the Company with regard to dealing in the Company’s securities.

The Company issues circulars or electronic mails to its Directors, key management personnel and employees that they must not trade in the shares of the Company during the period commencing one (1) month before the release of the half year and full year results and ending on the date of such announcements. In addition, Directors and key management personnel are expected to observe insider trading laws at all times even when dealing in securities within the permitted trading period. They should not deal in the Company’s shares on short term considerations.

Interested Person Transactions

The Company has established procedures to ensure that all transactions with interested persons are reported in a timely manner to the Audit Committee and that the transactions are carried out on normal commercial terms and shall not be prejudicial to the interests of the Company and its minority Shareholders. When a potential conflict of interest arises, the Director concerned takes no part in discussions nor exercises any influences over other members of the Board.

The Group has not obtained a general mandate from Shareholders for interested person transactions. During the financial year under review, there were no interested person transactions entered into by the Group that requires disclosure pursuant to the Catalist Rules.

Material Contracts

Other than disclosed in the audited financial statements and the service agreement between the Executive Chairman and Chief Executive Officer, and the Company, there were no material contracts (including loans) entered into by the Company or its wholly-owned subsidiary involving the interests of the Executive Chairman and Chief Executive Officer, any Director or controlling Shareholders, which are either still subsisting as at the end of FY2023 or if not then subsisting, entered into since the end of the previous financial year.

Fees Paid to External Auditors

Ernst & Young LLP (“EY”), the external auditors of the Company, rendered the following services (and charged the fees) set out below for FY2023:

     
   

FY2023

   

S$’000

Audit fees  

   

       Statutory audit

  91
Non-audit fees    
Non-audit related    

        Tax returns compliance service – Current year 

 

9.5

Audit related services

 

 

        Half-year results review

 

6

       Proposed Acquisition fees*

 

53

Total audit and non-audit fees

 

159.5

 

*              Presented RTO fees relates to the proposed acquisition of the entire issued and paid-up share capital in AlDigi Holdings Pte. Ltd. from RHT AlDigi Financial Holdings Pte. Ltd. (“Proposed Acquisition”), which is one-off in nature.

The amount of non-audit fees (excluding the audit related services) does not exceed 50% of the total annual audit fees charged by EY in FY2023.

The Audit Committee has reviewed all non-audit services (described above) provided by EY and is of the view that they did not affect the independence and objectivity of EY, as EY has confirmed its compliance with the Singapore Accountants (Public Accountants) Rules in respect of its independence to act as the auditor of the Company.

 

Non-Sponsorship Fees

During FY2022, the Company’s Sponsor, ZICO Capital Pte. Ltd. (“ZICO Capital”) was appointed as the Financial Adviser to the Company for the Proposed Acquisition. Pursuant to the Proposed Acquisition, the financial advisory fees of $180,000 (excluding GST) were payable or paid to ZICO Capital in FY2023 (FY2022: $120,000).

Save as disclosed above, with reference to Rule 1204(21) of the Catalist Rules, there were no other non-sponsorship fees payable or paid to the Company’s sponsor, ZICO Capital, for FY2023.

ADDITIONAL INFORMATION ON DIRECTORS NOMINATED FOR RE-ELECTION – APPENDIX 7F TO THE CATALIST RULES

Pursuant to Rule 720(5) of the Catalist Rules, the information as set out in Appendix 7F to the Catalist Rules relating to Mr Tan Tong Guan and Mr Kim Seah Teck Kim, being the Directors who are retiring and nominated for re-election in accordance with the Company’s Constitution at the forthcoming AGM, is set out below:

Name of Director

Tan Tong Guan

Kim Seah Teck Kim 

Date of first appointment

17 February 2010

25 April 2019

 

Date of last re-appointment

(if applicable)

25 April 2022

25 April 2022

Age

60

69

Country of principal residence

Singapore

Singapore

The Board’s comments on this re-election (including rationale, selection criteria, and the search and nomination process)

The Board of Directors of the Company has accepted and approved the Nominating Committee’s recommendation, who has reviewed and considered Mr Tan Tong Guan’s (“Mr Tan”) contributions and performance as Executive Chairman and Chief Executive Officer of the Company, and the diversity of the Board of Directors of the Company with regards to the objectives of the Board Diversity Policy of the Company.

The Board of Directors of the Company has accepted and approved the Nominating Committee’s recommendation, who has reviewed and considered Mr Kim Seah Teck Kim’s (“Mr Seah”) contributions and performance as an Independent Director of the Company, and the diversity of the Board of Directors of the Company with regards to the objectives of the Board Diversity Policy of the Company.

Mr Seah, being a member of the Nominating Committee, has abstained from making any recommendation and/or participating in any deliberation of the Nominating Committee and the Board in respect of the assessment of his own performance or re-election as a Director of the Company.

Whether appointment is executive, and if so, the area of responsibility

Executive. Mr Tan is responsible for providing the corporate direction and business strategy of the Group.

Non-Executive

Job title

Executive Chairman and Chief Executive Officer

Independent Director, the Chairman of Nominating Committee and Remuneration Committee, as well as a member of Audit Committee

Professional qualifications

  • Bachelor of Accountancy from the
    National University of Singapore
  • Fellow Chartered Accountant of Singapore with the Institute of Singapore Chartered Accountants
  • Master of Laws (Harvard)

  • Bachelor of Laws (Hons) (Singapore)

  • Advocate & Solicitor

  • Fellow & Principal Mediator, Singapore Mediation Centre

Working experience and occupation(s) during the past 10 years

February 2010 to Present: Executive Chairman and Chief Executive Officer of the Company

February 1991 to Present: Executive Director of Tan Gee Beng Private Limited

July 2003 to July 2016: Executive Chairman of Smartflex Technology Pte Ltd

2021 to Present: Incisive Law LLC, Director

2018 to 2021: Incisive Law LLC, Consultant

1998 to 2018: A Ang Seah & Hoe, Partner

Shareholding interest in the listed issuer and its subsidiaries

Yes

As at 21 March 2024: 

Direct interest – 1,726,501 ordinary shares of the Company

Deemed interest – 57,539,331 ordinary shares of the Company

No

Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries

Mr Tan is a shareholder of the Company, details as set out above.

Mr Tan is the brother of Ms Tan Geok Moey, the Non Executive Director of the Company.

Mr Tan is also related to the other substantial shareholders of the Company, namely, Tan Gee Beng Private Limited, Ms Tan Geok Moey and Ms Tan Yoke Hong. Mr Tan is a director of Tan Gee Beng Private Limited, and the brother of Ms Tan Geok Moey and Ms Tan Yoke Hong.

Mr Tan is a director of the Company’s wholly-owned subsidiary, AVH Animal Ark Pte. Ltd..

Nil

Conflict of interest (including any competing business)

Nil

Nil

Undertaking (in the format set out in Appendix 7H) under Rule 720(1) has been submitted to the listed issuer

Yes

Yes

Other Principal Commitments

Including Directorships

Past (for the last 5 years)

Directorships

  • Teck Gee Investments (International)
    Pte Ltd
  • NZ First Properties Pte. Ltd.

Other Principal Commitment
Nil

Present

Directorships

  •  Tan Gee Beng Private Limited

  • Sing Holdings Limited

  • TGB Properties Pte. Ltd.

  • Perusahaan TGB Sdn Bhd

  • Centrepoint Tiara (M) Sdn Bhd

  • TGB Properties (NZ) Pte. Ltd.

  • Cosmos Investment Pte Ltd
  • Tan Gee Beng (Hong Kong) Limited

  • Suzhou Hongchang Packing

  • Ningbo Shino Cosmetic Cotton Co. Ltd

  • D.E. Cosmetics Ningbo Co. Ltd

  • Wellington First Properties (NZ) Pte. Ltd.

  • AVH Animal Ark Pte. Ltd.

 

Other Principal Commitment
Nil

Past (for the last 5 years)

Directorship

  • Sing Investments & Finance Limited

Present

Directorships

  • The Anglo-Chinese Schools Foundation Limited

  • Camelot Trustees Limited

  • ACS (International)

  • Oldham Enterprise Pte Ltd

  • Incisive Law LLC

  • AVH Animal Ark Pte. Ltd.

Other Principal Commitment

  • The Association of Banks in Singapore (Legal Adviser)

  • Paris-based International Chamber of Commerce Banking Commission (Member)

  • ICC DOCDEX panel (Appointed Expert)

  • Singapore Mediation Centre (Fellow Member)

  • Patron Dispute Committee of the Casino Regulatory Authority, Singapore (Chairman)

  • Disciplinary Panels of –

    • (i) the Law Society of Singapore (Member)
    • (ii) Singapore Medical Council (Member)
    • (iii) Singapore Pharmacy Council (Member)
    • (iv) Public Service Commission, Singapore (Member)

Disclose the following matters concerning an appointment of director, chief executive officer, chief financial officer, chief operating officer, general manager or other officer of equivalent rank. If the answer to any question is “yes”, full details must be given.

(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?

No

No

(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?

No

No

(c) Whether there is any unsatisfied judgment against him?

No

No

(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?

No

No

(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?

No

No

(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?

No

No

(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?

No

No

(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?

No

No

(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?

No

No

(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of:–

  1. any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
  2. any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
  3. any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
  4. any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?

No

No

(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?

No

No

 



Whistleblowing Policy

SCOPE

This policy applies to all directors, officers, employees, including full-time, part-time and contract employees  of ASIA VETS HOLDINGS LTD. (the “Company”), its subsidiaries and associated companies (together with the Company, the “Group”), whether located in Singapore or elsewhere.

PURPOSE

The Group is committed to the highest possible standards of ethical, moral and legal business conduct. In line with this commitment and the Group’s commitment to open communication and good corporate  governance, this policy aims to provide a framework by which employees and external parties may raise concerns in confidence about wrongdoing, malpractice or possible irregularity within the Group and offer  reassurance that they will be protected from reprisals or victimisation for whistle blowing in good faith and without malice.

POLICY

This policy is intended to cover concerns over wrongdoing or malpractice within or by the Group (“Alleged Wrongful Act”), including, without limitation, actions that:

  • – may lead to incorrect financial reporting;
  • – may be questionable accounting or auditing matters
  • – are unlawful;
  • – are in breach of a legal obligation or contrary to any Group policy;
  • – may pose dangers to the health and safety of any individual;
  • – may damage the environment;
  • – may amount to professional or ethical malpractices;
  • – conceals wrongdoings or malpractices;
  • – may pose breach of fundamental internal control;
  • – misappropriates assets or funds of the Group;
  • – constitute violations of this policy;
  • – otherwise amount to improper conduct; or
  • – are intended to conceal any of the above.
  • – abuse of power and authority

SAFEGUARDS

4.1 Harassment or Victimisation

Harassment, or victimisation of the complainant in retaliation for raising concerns over any Alleged  Wrongful Act will not be tolerated and appropriate steps will be taken to ensure the complainant suffers  no detriment or retaliation as a result of raising concerns over Alleged Wrongful Act.

Victimisation includes termination of employment; demotion; suspension; written reprimand; retaliatory  investigation; decision not to promote; receipt of an unwarranted performance rating; withholding of appropriate salary adjustments; elimination of the employees’ position, absent an overall reduction in work force, reorganisation, or a decrease in or lack of sufficient funding, monies, or work load; or denial of awards, grants, leaves or benefits for which the employee is then eligible, or discrimination or threats of any form.

4.2 Confidentiality

Every effort will be made to protect the complainant’s identity, if so requested, so long as is compatible with a proper investigation. However, it is important to be aware that it may be necessary to reveal the identity of the complainant, to assist in investigation under certain circumstances such as:

a) Where the Group is under a legal obligation to disclose information provided

b) Where the information is already in public domain

c) Where the information is given on a strictly confidential basis to legal or auditing professionals for  the purpose of obtaining professional advice

d) Where the information is given to the Police or other authorities for criminal investigation

In the event we are faced with a circumstance not covered by the above, and where the complainant’s  identity is to be revealed, we will endeavour to discuss this with the complainant first.

4.3 Anonymous Allegations

The policy encourages employees to put their names to allegations because appropriate follow-up questions and investigations may not be possible unless the source of the information is identified. Concerns expressed anonymously will be investigated, but consideration will be given to:

– the seriousness of the issue raised;
– the credibility of the concern; and
– the likelihood of confirming the allegation from attributable sources.

4.4 Malicious Allegations

Employees who raise a concern in good faith, which is shown to be unsubstantiated by subsequent investigation, will not have action taken against them. However, an employee who makes an allegation maliciously, in bad faith or knowing it to be untrue or unfounded, may be subject to disciplinary action.

 

REPORTING PROCEDURES

5.1 Reporting

  1. Any employee shall report promptly to the Chairman of the AC of any unethical or improper practices regarding any item within the scope of this Policy, who shall promptly thereafter provide notice to the board of directors as appropriate.

    • The Chairman of the Audit Committee:
    • Mr. Henry Tan
    • Email address: henrytan@sg.cla-ts.com
  2. The Chairman of the AC shall notify the sender and acknowledge receipt of the complaint promptly.
  3. All such questions, concerns, suggestions or complaints shall be sent in writing to the Chairman of the AC.

5.2 Timing

All complaints should be made as soon as practicable to enable the Group to take action.

5.3 Evidence

The report should be sufficiently detailed, setting out the background and history of events and reasons for the concern so as to provide the necessary information to Chairman of the Audit Committee as to the nature of the Alleged Wrongful Act. Although the employee is not expected to prove the truth of an allegation, the employee is encouraged to provide such evidence so as to demonstrate that there are sufficient grounds for concern. If the complainant is not comfortable about writing in, the complainant can telephone or meet the appropriate officer in confidence at a time and location to be determined together.

The Group also recognises that the complainant may wish to seek advice and be represented by the complainant’s trade union officer.

5.4 How the Complaint will be handled

The action taken will depend on the nature of the concern, initial inquiries will be made to determine whether an investigation is appropriate, and the form that it should take. Some concerns may be resolved without the need for investigation.

The Group assures you that any concern raised on information provided will be investigated, but consideration will be given to these factors:

  • Severity of the issue raised
  •  Credibility of the concern or information
  • Likelihood of confirming the concern or information from attributable sources

5.5 Report to Complainant

Subject to legal constraints, the complainant will be given the opportunity to receive follow-up notification on his/her concern within 2 weeks of the complaint:

–  acknowledging that the concern was received;
–  indicating how the matter will be dealt with;
–  giving an estimate of the time that it will take for a final response;
–  telling them whether initial inquiries have been made;
–  notifying them of reason(s) should it be decided that no action is to be taken.

5.6 Further Information

The amount of contact between the complainant and the body investigating the concern will depend on the nature of the issue and the clarity of information provided. Further information may be sought from the complainant.

5.7 Information

Subject to legal constraints the complainant will receive information about the outcome of any investigations.

5.8 Monitoring

The Audit Committee will maintain a record of concerns raised under this policy and the outcomes (but in a form which does not endanger confidentiality and where applicable, protect identity of the complainant) and will report as necessary to the Board of Directors.

5.9 Dissemination of Policy

A copy of this policy and any subsequent amendments or modification thereof, shall be made available by the [administration department/ HR department] to all directors, officers, employees, including full-time, part-time and contract employees of the Group, through publication at the [notice board/website] of the Group companies or such other means as may be approved by Audit Committee.

5.10 Maintenance of the policy

The Audit Committee has the responsibility for ensuring the maintenance, regular review and updating of this policy. Revisions, amendments and alterations to this policy can only be implemented upon  approval by the Audit Committee and the Board of Directors and must be notified in writing to the employees when they occur.